320 related articles for article (PubMed ID: 20381617)
1. Indirubin-3'-monoxime rescues spatial memory deficits and attenuates beta-amyloid-associated neuropathology in a mouse model of Alzheimer's disease.
Ding Y; Qiao A; Fan GH
Neurobiol Dis; 2010 Aug; 39(2):156-68. PubMed ID: 20381617
[TBL] [Abstract][Full Text] [Related]
2. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease.
Imbimbo BP; Giardino L; Sivilia S; Giuliani A; Gusciglio M; Pietrini V; Del Giudice E; D'Arrigo A; Leon A; Villetti G; Calzà L
J Alzheimers Dis; 2010; 20(1):159-73. PubMed ID: 20164581
[TBL] [Abstract][Full Text] [Related]
3. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
[TBL] [Abstract][Full Text] [Related]
4. Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses.
Lee JK; Jin HK; Endo S; Schuchman EH; Carter JE; Bae JS
Stem Cells; 2010 Feb; 28(2):329-43. PubMed ID: 20014009
[TBL] [Abstract][Full Text] [Related]
5. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.
Toledo EM; Inestrosa NC
Mol Psychiatry; 2010 Mar; 15(3):272-85, 228. PubMed ID: 19621015
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model.
Ding Y; Qiao A; Wang Z; Goodwin JS; Lee ES; Block ML; Allsbrook M; McDonald MP; Fan GH
J Neurosci; 2008 Nov; 28(45):11622-34. PubMed ID: 18987198
[TBL] [Abstract][Full Text] [Related]
7. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
[TBL] [Abstract][Full Text] [Related]
8. Fluoro-Jade B staining as useful tool to identify activated microglia and astrocytes in a mouse transgenic model of Alzheimer's disease.
Damjanac M; Rioux Bilan A; Barrier L; Pontcharraud R; Anne C; Hugon J; Page G
Brain Res; 2007 Jan; 1128(1):40-9. PubMed ID: 17125750
[TBL] [Abstract][Full Text] [Related]
9. Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice.
Pan X; Gong N; Zhao J; Yu Z; Gu F; Chen J; Sun X; Zhao L; Yu M; Xu Z; Dong W; Qin Y; Fei G; Zhong C; Xu TL
Brain; 2010 May; 133(Pt 5):1342-51. PubMed ID: 20385653
[TBL] [Abstract][Full Text] [Related]
10. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.
Heikkinen T; Kalesnykas G; Rissanen A; Tapiola T; Iivonen S; Wang J; Chaudhuri J; Tanila H; Miettinen R; Puoliväli J
Exp Neurol; 2004 May; 187(1):105-17. PubMed ID: 15081593
[TBL] [Abstract][Full Text] [Related]
11. Vitamin C restores behavioral deficits and amyloid-β oligomerization without affecting plaque formation in a mouse model of Alzheimer's disease.
Murakami K; Murata N; Ozawa Y; Kinoshita N; Irie K; Shirasawa T; Shimizu T
J Alzheimers Dis; 2011; 26(1):7-18. PubMed ID: 21558647
[TBL] [Abstract][Full Text] [Related]
12. Possible involvement of transthyretin in hippocampal beta-amyloid burden and learning behaviors in a mouse model of Alzheimer's disease (TgCRND8).
Doggui S; Brouillette J; Chabot JG; Farso M; Quirion R
Neurodegener Dis; 2010; 7(1-3):88-95. PubMed ID: 20173334
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-beta levels are significantly reduced and spatial memory defects are rescued in a novel neuroserpin-deficient Alzheimer's disease transgenic mouse model.
Fabbro S; Schaller K; Seeds NW
J Neurochem; 2011 Sep; 118(5):928-38. PubMed ID: 21689108
[TBL] [Abstract][Full Text] [Related]
15. Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice.
Arendash GW; Mori T; Cao C; Mamcarz M; Runfeldt M; Dickson A; Rezai-Zadeh K; Tane J; Citron BA; Lin X; Echeverria V; Potter H
J Alzheimers Dis; 2009; 17(3):661-80. PubMed ID: 19581722
[TBL] [Abstract][Full Text] [Related]
16. Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease.
Grossi C; Francese S; Casini A; Rosi MC; Luccarini I; Fiorentini A; Gabbiani C; Messori L; Moneti G; Casamenti F
J Alzheimers Dis; 2009; 17(2):423-40. PubMed ID: 19363260
[TBL] [Abstract][Full Text] [Related]
17. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
18. Age-dependent increase in lysosome-associated membrane protein 1 and early-onset behavioral deficits in APPSL transgenic mouse model of Alzheimer's disease.
Hashimoto T; Ogino K; Shin RW; Kitamoto T; Kikuchi T; Shimizu N
Neurosci Lett; 2010 Jan; 469(2):273-7. PubMed ID: 20025930
[TBL] [Abstract][Full Text] [Related]
19. Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse.
Gordon MN; Holcomb LA; Jantzen PT; DiCarlo G; Wilcock D; Boyett KW; Connor K; Melachrino J; O'Callaghan JP; Morgan D
Exp Neurol; 2002 Feb; 173(2):183-95. PubMed ID: 11822882
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]